Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Basal Cell Carcinoma 2025
The Journal of Dermatology · 2026
DOI: 10.1111/1346-8138.70050 ↗Kurz gefasst
Leitlinie in der Zeitschrift The Journal of Dermatology, 2026. Verfasst von Toshihiko Hoashi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nippon Medical School, Tokyo, Japan. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Dermatology, Skin Neoplasms. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Japanese Dermatological Association.
Abstract (Originalsprache)
In accordance with the advancement of therapies for skin malignancies, the Japanese Dermatological Association and Japanese Skin Cancer Society updated guidelines for skin malignancies to reflect current clinical practices. Basal cell carcinoma (BCC) is one of the most ordinary malignant cutaneous tumors and its incidence continues to grow in many countries. Clinically, BCCs in East Asian populations are usually pigmented, and 88.3% of total BCCs in Japanese patients are pigmented. However, a low proportion of BCCs in Western populations are pigmented. Therefore, diagnosis and tumor border evaluation of BCCs in Western populations are relatively difficult. From these characteristics, clinical guidelines for East Asian BCCs should differ from those for Western BCCs. This revised Japanese clinical guideline for BCC was also undertaken by a committee comprising experts across relevant fields who meticulously reviewed and systematized a wide range of literature on BCC to develop comprehensive, evidence‐based guidelines. Literature searches were conducted by the Japan Medical Library in accordance with the Minds Clinical Practice Guideline Creation Manual 2020, ver. 3.0. Four clinical questions (CQs) were established, and corresponding recommendation statements were provided for each CQ. There are about the reduced margin resection for pigmented BCCs, the radiotherapy for the recurrent BCCs, the topical immune response modifiers, and the systemic therapy using immune checkpoint inhibitors. This Japanese clinical guideline for BCC will help clinicians select suitable therapies for BCCs in East Asia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Nippon Medical School, Tokyo, Japan.
- Department of Dermatology, Saitama Cancer Center, Saitama, Japan.
- Department of Dermatologic Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Radiology, Kawasaki Medical School, Kurashiki, Japan.
- Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
- Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
ORCID-Profile: Toshihiko Hoashi, Nobuhiko Kamitani, Shintaro Maeda, Yoshio Nakamura, Tomomitsu Miyagaki, Hiroshi Koga, Hiroshi Uchi
Förderung
- Japanese Dermatological Association
Zitieren
APA
Hoashi, T., Ishikawa, M., Uehara, J., Kamitani, N., Maeda, S., Nakamura, Y., Shichinohe, R., Hirabayashi, M., Miyagaki, T., Koga, H., Nakamura, Y., & Uchi, H. (2026). Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Basal Cell Carcinoma 2025. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70050
Vancouver
Hoashi T, Ishikawa M, Uehara J, Kamitani N, Maeda S, Nakamura Y, et al. Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Basal Cell Carcinoma 2025. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70050
BibTeX
@article{Hoashi2026,
author = {Hoashi, Toshihiko and Ishikawa, Masashi and Uehara, Jiro and Kamitani, Nobuhiko and Maeda, Shintaro and Nakamura, Yoshio and Shichinohe, Ryuji and Hirabayashi, Megumi and Miyagaki, Tomomitsu and Koga, Hiroshi and Nakamura, Yasuhiro and Uchi, Hiroshi},
title = {Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Basal Cell Carcinoma 2025},
journal = {The Journal of Dermatology},
year = {2026},
doi = {10.1111/1346-8138.70050}
}
EUVIMED